- Therapy-Related Acute Megakaryoblastic Leukemia in a Lung Cancer Patient
-
Moon JJ, Nam MH, Lim CS, Lee CK, Cho Y, Yoon SY
- KMID: 1791911
- Ann Lab Med.
- 2014 Mar;34(2):155-158.
- doi: 10.3343/alm.2014.34.2.155
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of FOLFIRI after Failure of FOLFOX-4 in Advanced Gastric Cancer
-
Kwon HJ, Park MI, Park SJ, Moon W, Kim SE, Lee HW, Choi YJ, Kim JH
- KMID: 2373306
- Korean J Gastroenterol.
- 2015 Jul;66(1):10-16.
- doi: 10.4166/kjg.2015.66.1.10
BACKGROUND/AIMS: The purpose of this study was to investigate the efficacy and safety of irinotecan based FOLFIRI chemotherapy as a second-line treatment after failure of FOLFOX-4 chemotherapy in patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Current status of chemotherapy for the treatment of advanced biliary tract cancer
-
Sasaki T, Isayama H, Nakai Y, Koike K
- KMID: 1780097
- Korean J Intern Med.
- 2013 Sep;28(5):515-524.
- doi: 10.3904/kjim.2013.28.5.515
Chemotherapy is indispensable for the treatment of advanced biliary tract cancer. Recently, reports regarding first-line chemotherapy have increased, and first-line chemotherapy treatment has become gradually more sophisticated. Gemcitabine and cisplatin... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatic Lesions that Mimic Metastasis on Radiological Imaging during Chemotherapy for Gastrointestinal Malignancy: Recent Updates
-
You SH, Park BJ, Kim YH
- KMID: 2427297
- Korean J Radiol.
- 2017 Jun;18(3):413-426.
- doi: 10.3348/kjr.2017.18.3.413
During chemotherapy in patients with gastrointestinal malignancy, the hepatic lesions may occur as chemotherapy-induced lesions or tumor-associated lesions, with exceptions for infectious conditions and other incidentalomas. Focal hepatic lesions arising... -
- CITED
-
- Close
- SHARE
-
- Close
- Patterns of Neutropenia and Risk Factors for Febrile Neutropenia of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP
-
Choi YW, Jeong SH, Ahn MS, Lee HW, Kang SY, Choi JH, Jin UR, Park JS
- KMID: 2069930
- J Korean Med Sci.
- 2014 Nov;29(11):1493-1500.
- doi: 10.3346/jkms.2014.29.11.1493
Febrile neutropenia (FN) is the major toxicity of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) regimen in the treatment of diffuse large B-cell lymphoma (DLBCL). The prediction of neutropenia... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical characteristics and outcomes in diffuse large B cell lymphoma patients aged 70 years and older: a single-center experience with a literature review
-
Jung YH, Woo IS, Han CW
- KMID: 2381567
- Korean J Intern Med.
- 2015 Sep;30(5):684-693.
- doi: 10.3904/kjim.2015.30.5.684
BACKGROUND/AIMS: Among diffuse large B cell lymphoma (DLBCL) patients, determining the appropriate dose and chemotherapy schedule to balance toxicity and efficacy is harder in elderly than in younger patients. Moreover,... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence and Characteristics of Chemotherapy-related Cognitive Impairment in Patients with Breast Cancer
-
Park JH, Bae SH, Jung YS, Jung YM
- KMID: 2363068
- J Korean Acad Nurs.
- 2015 Feb;45(1):118-128.
- doi: 10.4040/jkan.2015.45.1.118
PURPOSE: Evidence suggests that some patients with breast cancer experience cognitive difficulties following chemotherapy. This longitudinal study was done to examine the prevalence of cognitive impairment and trajectory of cognitive... -
- CITED
-
- Close
- SHARE
-
- Close
- Bi-weekly Chemotherapy of Paclitaxel and Cisplatin in Patients with Metastatic or Recurrent Esophageal Cancer
-
Cho SH, Chung IJ, Song SY, Yang DH, Byun JR, Kim YK, Lee JJ, Na KJ, Kim HJ
- KMID: 1712743
- J Korean Med Sci.
- 2005 Aug;20(4):618-623.
- doi: 10.3346/jkms.2005.20.4.618
Although various combinations of chemotherapy regimens have been tried for patients with esophageal cancer, their duration of survival is extremely poor. In this study, we investigated the safety and clinical... -
- CITED
-
- Close
- SHARE
-
- Close
- The Role of Pharmacoethnicity in the Development of Cytotoxic and Molecular Targeted Drugs in Oncology
-
Saijo N
- KMID: 1776911
- Yonsei Med J.
- 2013 Jan;54(1):1-14.
- doi: 10.3349/ymj.2013.54.1.1
The effective and toxic ranges of anticancer drugs are very narrow and, in some cases, inverted. Thus determination of the most appropriate dosage and schedule of administration is crucial for... -
- CITED
-
- Close
- SHARE
-
- Close
- A Less Intensive Combination of Paclitaxel and Carboplatin in Advanced Non-small Cell Lung Cancer Patients who Have Aged 60 Years or More and Has a Poor Performance Status
-
Min YJ, Ahn JJ, Noh YJ, Cha HJ, Suh JH, Jung JP, Park CR, Jeong AK, Park JH, Lee KM
- KMID: 759697
- Korean J Intern Med.
- 2004 Jun;19(2):109-113.
BACKGROUND: The aim of this study was to evaluate the response, survival, and toxicities of a less intensive combination of paclitaxel and carboplatin, which is used in advanced non-small cell... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical significance of nuclear factor kappaB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy
-
Shin HC, Seo J, Kang BW, Moon JH, Chae YS, Lee SJ, Lee YJ, Han S, Seo SK, Kim JG, Sohn SK, Park TI
- KMID: 2070136
- Korean J Intern Med.
- 2014 Nov;29(6):785-792.
- doi: 10.3904/kjim.2014.29.6.785
BACKGROUND/AIMS: This study investigated the expression of nuclear factor kappaB (NF-kappaB) and the chemokine receptor (CXCR4) in patients with diffuse large B-cell lymphoma (DLBCL) who received rituximab-based therapy. METHODS: Seventy patients... -
- CITED
-
- Close
- SHARE
-
- Close
